The Role of Inflammation in Age-Related Macular Degeneration.

The Role of Inflammation in Age-Related Macular Degeneration.
复制标题

炎症在年龄相关性黄斑变性中的作用。

DOI:
10.7150/ijbs.49890
复制
发表时间:
2020
影响因子:
9.2
通讯作者:
Zhou Y
Zhou Y
中科院分区:
生物学2区
文献类型:
--
作者:
Tan W;Zou J;Yoshida S;Jiang B;Zhou Y

文献摘要

参考文献

被引文献

相似文献

视网膜相关性黄斑变性(AMD)是一种致盲性眼病,其发病率随着年龄的增长而逐渐增加。炎症参与AMD的发病机制,包括脉络膜新生血管和地图样萎缩。这也是一种自我保护的调节,使眼睛免受伤害。本文综述了炎症在AMD发病机制中的作用,并对炎症相关细胞因子(包括促炎细胞因子和抗炎细胞因子)以及白细胞(巨噬细胞、树突状细胞、中性粒细胞、T淋巴细胞和B淋巴细胞)在AMD先天性或获得性免疫中的作用进行了综述。还讨论了可能的临床应用,例如潜在的诊断生物标志物和抗炎疗法。本文综述了炎症作为治疗AMD的新的有效治疗方法的目标。
Age-related macular degeneration (AMD) is a blinding eye disease which incidence gradually increases with age. Inflammation participates in AMD pathogenesis, including choroidal neovascularization and geographic atrophy. It is also a kind of self-protective regulation from injury for the eyes. In this review, we described inflammation in AMD pathogenesis, summarized the roles played by inflammation-related cytokines, including pro-inflammatory and anti-inflammatory cytokines, as well as leukocytes (macrophages, dendritic cells, neutrophils, T lymphocytes and B lymphocytes) in the innate or adaptive immunity in AMD. Possible clinical applications such as potential diagnostic biomarkers and anti-inflammatory therapies were also discussed. This review overviews the inflammation as a target of novel effective therapies in treating AMD.
DOI: 10.1371/journal.pmed.0030310
发表时间: 2006-08
期刊: PLOS MEDICINE
影响因子: 15.8
作者:
Apte, Rajendra S.;Richter, Jennifer;Herndon, John;Ferguson, Thomas A.
通讯作者: Ferguson, Thomas A.
DOI: 10.12688/f1000research.10664.1
发表时间: 2017
期刊: F1000Research
影响因子: --
作者:
Bandello F;Sacconi R;Querques L;Corbelli E;Cicinelli MV;Querques G
通讯作者: Querques G
DOI: 10.1016/j.omtm.2020.01.006
发表时间: 2020-06-12
影响因子: 4.7
作者:
Chung, Sook Hyun;Mollhoff, Iris Natalie;Yiu, Glenn
通讯作者: Yiu, Glenn
DOI: 10.1016/j.ophtha.2017.05.035
发表时间: 2017-12
期刊: Ophthalmology
影响因子: 13.7
作者:
Colijn JM;Buitendijk GHS;Prokofyeva E;Alves D;Cachulo ML;Khawaja AP;Cougnard-Gregoire A;Merle BMJ;Korb C;Erke MG;Bron A;Anastasopoulos E;Meester-Smoor MA;Segato T;Piermarocchi S;de Jong PTVM;Vingerling JR;Topouzis F;Creuzot-Garcher C;Bertelsen G;Pfeiffer N;Fletcher AE;Foster PJ;Silva R;Korobelnik JF;Delcourt C;Klaver CCW;EYE-RISK consortium;European Eye Epidemiology (E3) consortium
通讯作者: European Eye Epidemiology (E3) consortium
DOI: 10.1016/j.jphotobiol.2016.05.018
发表时间: 2016-08-01
影响因子: 5.4
作者:
Brandstetter, Carolina;Patt, Joshua;Krohne, Tim U.
通讯作者: Krohne, Tim U.